Gene · 55851
PSENEN: presenilin enhancer, gamma-secretase subunit
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. PSENEN: presenilin enhancer, gamma-secretase subunit. Genes, record 55851. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/55851
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9NZ42 | Gamma-secretase subunit PEN-2 | 101 | 27 | Ensembl, GeneID, HGNC |
Source UniProt
Patents48
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 59039 | Q9NZ42 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 59040 | Q9NZ42 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 546 | Q9NZ42 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 3602 | Q9NZ42 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 3602 | Q9NZ42 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 546 | Q9NZ42 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 66560 | Q9NZ42 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 66561 | Q9NZ42 | Espacenet |
| US 11400116 B2 | 2022-08-02 | 7440 | Q9NZ42 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 169531 | Q9NZ42 | Espacenet |
1 to 10 of 48
See all 48 patentsDrugs7
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
| Drug | ChEMBL ID | Mechanism | Action | Source |
|---|---|---|---|---|
| AVAGACESTAT | CHEMBL1090771 | Gamma-secretase inhibitor | INHIBITOR | ChEMBL |
| BEGACESTAT | CHEMBL463981 | Gamma-secretase inhibitor | INHIBITOR | ChEMBL |
| NIROGACESTAT | CHEMBL1770916 | Gamma-secretase inhibitor | INHIBITOR | ChEMBL |
| NIROGACESTAT HYDROBROMIDE | CHEMBL4298153 | Gamma-secretase inhibitor | INHIBITOR | ChEMBL |
| RG-4733 | CHEMBL4297422 | Gamma-secretase inhibitor | INHIBITOR | ChEMBL |
| SEMAGACESTAT | CHEMBL520733 | Gamma-secretase inhibitor | INHIBITOR | ChEMBL |
| TARENFLURBIL | CHEMBL190083 | Gamma-secretase modulator | MODULATOR | ChEMBL |
Trials67
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
| Trial | Drug | Phase | Results first posted | Source |
|---|---|---|---|---|
| NCT07539454 | NIROGACESTAT | PHASE2 | ClinicalTrials.gov | |
| NCT07176689 | NIROGACESTAT | PHASE4 | ClinicalTrials.gov | |
| NCT07170644 | NIROGACESTAT | PHASE2 | ClinicalTrials.gov | |
| NCT07150104 | NIROGACESTAT | PHASE1/PHASE2 | ClinicalTrials.gov | |
| NCT07150091 | NIROGACESTAT | PHASE1/PHASE2 | ClinicalTrials.gov | |
| NCT07084896 | NIROGACESTAT | PHASE1/PHASE2 | ClinicalTrials.gov | |
| NCT05949099 | NIROGACESTAT | PHASE2 | ClinicalTrials.gov | |
| NCT05879146 | NIROGACESTAT | PHASE2 | ClinicalTrials.gov | |
| NCT05573802 | NIROGACESTAT | PHASE1/PHASE2 | ClinicalTrials.gov | |
| NCT05556798 | NIROGACESTAT | PHASE1 | ClinicalTrials.gov |
1 to 10 of 67
See all 67 trialsNIH grants839
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | PSENEN papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 12 | 2025 |
| U24AG021886 | National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD) | 7 | 2025 |
| P30CA168524 | The University of Kansas Cancer Center | 5 | 2025 |
| ZIAAG000311 | ALZHEIMERS RESEARCH PROJECT: Design And Development Of Experimental Therapeutics ((Systemic & Neurodegenerative Disorders and Alzheimer's Disease) | 4 | 2025 |
| P01AG026276 | Antecedent Biomarkers for Alzheimer Disease: The Adult Children Study | 3 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| T32AG000222 | Training in the Molecular Biology of Neurodegeneration and Alzheimer's Disease | 3 | 2025 |
| U19AG032438 | Bridge Funding for Dominantly Inherited Alzheimer Network | 3 | 2025 |
| U54CA132378 | 1/2 CCNY-MSK Partnership for Cancer Research, Education and Community Outreach | 3 | 2025 |
| U54CA137788 | 2/2 CCNY-MSKCC Partnership for Cancer Research, Education and Community Outreach | 3 | 2025 |
1 to 10 of 839Source NIH's project files
See all 839 nih grantsPapers1,301
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systemic Molecular Network Alterations Associated with FoxA2 in Gastric Cancer. | Int J Mol Sci | 2026 | 42511485 | PubTator, text mining | PubMed |
| Differential DNA Methylation and Delirium After Anesthesia and Surgery. | medRxiv | 2026 | 42369472 | PubTator, text mining | PubMed |
| Metformin Redirects Autophagy from Bulk Turnover to Mitochondrial Clearance. | bioRxiv | 2026 | 42282636 | PubTator, text mining | PubMed |
| Penetratin: Structure and Interactions with Lipid Membranes of Various Compositions. | J Phys Chem B | 2026 | 41960875 | PubTator, text mining | PubMed |
| Metformin Regulation of the Liver Circadian Clock and Metabolic Aging: A Systems Modeling Study. | Metabolites | 2026 | 41893357 | PubTator, text mining | PubMed |
| Exploring Gene Expression Patterns in Alzheimer's Disease Using a Human Microarray Data Meta-Analysis. | Biology (Basel) | 2026 | 41744654 | PubTator, text mining | PubMed |
| β-amyloid and β-amyloid precursor protein synthesis and processing: effects of exercise and exercise-related injury. | Front Cell Neurosci | 2026 | 41737532 | PubTator, text mining | PubMed |
| Whole blood gene expression moderates associations between AD biomarkers and cognitive decline in cognitively unimpaired older adults. | Alzheimers Dement | 2026 | 41724695 | PubTator, text mining | PubMed |
| In Silico Phosphoproteomic Analysis Reveals Divergent Regulation of Presenilin 1 and Presenilin 2. | Neuromolecular Med | 2026 | 41615513 | PubTator, text mining | PubMed |
| The role of metformin in extracellular matrix-based three-dimensional cell culture Models: A mini-review on therapeutic potentials. | Biochem Biophys Rep | 2026 | 41561225 | PubTator, text mining | PubMed |
1 to 10 of 1,301
See all 1,301 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/55851
GET https://conductscience.org/api/genes/v1/55851/patents?page=2